XML 220 R8.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash Flows from Operating Activities      
Net income $ 3,401 $ 2,556 $ 3,149
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Depreciation, amortization and accretion, net (159) (154) (40)
Deferred income tax expense (benefit) 125 18 155
Share-based compensation 193 187 170
Net realized investment (gains) losses 15 47 (1)
Net trading (gains) losses (7) (9) 16
Loss from equity method investments 19 27 36
Impairments and provision for loan and credit losses 9 (16) 98
Net (gains) losses of consolidated investment entities (13) 23 17
Changes in operating assets and liabilities      
Restricted and segregated investments 102 (8) (96)
Deferred acquisition costs 36 64 67
Policyholder account balances, future policy benefits and claims, and market risk benefits, net 3,831 3,071 623
Derivatives, net of collateral (1,696) (624) 315
Receivables 215 276 39
Brokerage deposits (55) (781) (345)
Accounts payable and accrued expenses 105 354 (219)
Current income tax, net 200 (387) 116
Other operating assets and liabilities of consolidated investment entities, net 1 (5) 2
Other, net 273 46 305
Net cash provided by (used in) operating activities 6,595 4,685 4,407
Available-for-Sale securities:      
Proceeds from sales 2,340 734 1,306
Maturities, sinking fund payments and calls 15,684 9,230 7,621
Purchases (18,536) (19,694) (22,034)
Proceeds from sales, maturities and repayments of mortgage loans 175 152 169
Funding of mortgage loans (413) (284) (207)
Proceeds from sales, maturities and collections of other investments 123 145 96
Purchase of other investments (158) (116) (99)
Purchase of investments by consolidated investment entities (1,125) (427) (961)
Proceeds from sales, maturities and repayments of investments by consolidated investment entities 1,117 643 615
Purchase of land, buildings, equipment and software (176) (184) (182)
Cash paid for written options with deferred premiums (57) (59) (619)
Cash received from written options with deferred premiums 22 43 204
Cash returned (paid) for acquisition of business, net of cash acquired 0 0 34
Cash paid for deposit receivables (33) (39) (45)
Cash received for deposit receivables 592 774 550
Other, net (106) (180) (31)
Net cash provided by (used in) investing activities (551) (9,262) (13,583)
Investment certificates:      
Proceeds from additions 4,942 11,193 8,343
Maturities, withdrawals and cash surrenders (7,212) (7,039) (4,339)
Policyholder account balances:      
Deposits and other additions 1,470 1,476 1,169
Net transfers from (to) separate accounts (176) (132) (162)
Surrenders and other benefits (1,765) (2,102) (1,459)
Change in banking deposits, net 809 3,193 6,885
Cash paid for purchased options with deferred premiums (148) (53) (197)
Cash received for purchased options with deferred premiums 229 251 378
Issuance of long-term debt, net of issuance costs 0 1,335 495
Repayments of long-term debt (561) (760) (510)
Dividends paid to shareholders (574) (550) (534)
Repurchase of common shares (2,448) (2,127) (1,978)
Borrowings of consolidated investment entities 1,273 0 341
Repayments of debt by consolidated investment entities (1,004) (275) (4)
Other, net 0 1 2
Net cash provided by (used in) financing activities (5,165) 4,411 8,430
Effect of exchange rate changes on cash (10) 31 (68)
Net increase (decrease) in cash and cash equivalents, including amounts restricted 869 (135) (814)
Cash and cash equivalents, including amounts restricted at beginning of period 8,620 8,755 9,569
Cash and cash equivalents, including amounts restricted at end of period 9,489 8,620 8,755
Supplemental Disclosures:      
Income taxes paid, net 496 1,036 500
Leased assets obtained in exchange for operating lease liabilities 39 67 47
Reconciliation of cash and cash equivalents, including amounts restricted:      
Restricted and segregated cash, cash equivalents and investments 1,444 1,635  
Less: Restricted and segregated investments (477) (579)  
Total cash and cash equivalents, including amounts restricted per consolidated statements of cash flows 9,489 8,620 8,755
Ameriprise Financial      
Supplemental Disclosures:      
Interest paid on debt 834 682 152
Reconciliation of cash and cash equivalents, including amounts restricted:      
Cash and cash equivalents 8,149 7,477  
Consolidated investment entities      
Supplemental Disclosures:      
Interest paid 176 177 $ 75
Reconciliation of cash and cash equivalents, including amounts restricted:      
Cash and cash equivalents $ 373 $ 87